✨️Clinical Perspective Spotlight✨️
Check out this article that highlights how #radiotheranostics is bringing teams together across #oncology through shared expertise, multidisciplinary practice, and patient‑centered cancer care through the lens of #RTTs.
The fact that people don't describe PET scans as "Antimatter snitching on cancer" is a failure of outreach. #antimatter #medicine #radiology #radiotheranostics #cancer
Are you ready for radioligand therapy? Join the next #ESMOOnAir webinar part of the Therapeutic Landscapes series:
- Science, clinical trials & system readiness for RLT
- Live expert Q&A
🔗 https://ow.ly/fsmX50XnByi
#Oncology #Radiotheranostics #CancerCare #RLT #MedicalEducation
Theranostics Europe 2026
𝗧𝗵𝗲𝗿𝗮𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟲 - Bridging Science and Patient Care in Precision Oncology and Beyond
𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗛𝗲𝗿𝗲: lnkd.in/eGSFq7nE
#theranosticseurope #Radionuclide #Radiopharmaceutical #Therapeuticisotopes #radiotheranostics #GlobalEngage
There are several strategies to improve the tumor:liver which could be explored to make this more viable a #radiotheranostics agent
First up, Julia! We recruited her from the Morris’ lab at the UW Madison. During her 2 yrs, she worked across several projects, but her main project was assessed the potential of an understudied #HCC selective target for #radiotheranostics (under review) !
2/8
Lauren Wehner is presenting on advances in #radiotheranostics for targeted alpha therapy at #SNMMI25 this morning!
@snm-mi.bsky.social
One final note: You'll notice that in the RNAseq data of PDXs/PDOs, there's another target we highlighted #DLL3, which is also expressed in SCLC and NEPC and is being pursued as a target for these cancers including #radiotheranostics
doi.org/10.1016/S147...
Work pursuing #GPC3 #radiotheranostics using PDX models could validate these findings and offer a much needed therapeutic option for this rare, difficult to treat cancer.
And when tested one of our #GPC3-selective #radiotheranostics pairs, we observed nice localization and therapeutic benefit in H660 xenograft models!
Gastrin-releasing peptide receptor is a promising target for #cancer #radiotheranostics.
In #ACSMedChemLett, Tsuchihashi et al. report a novel GRPR-targeted radioligand with favourable pharmacokinetics & a high-level accumulation in tumours.
> pubs.acs.org/doi/10.1021/...
#OncologyInnovation
🚨 Fellow #radiotheranostics nerds 🚨
Prof. Tim Witney and I are launching a Collection focused on this very topic for NPJ Imaging
Please considering submitting! Site is live!
#radiopharmaceuticals #nucmed #radonc
At #AACR24 this year, I was tasked with presenting an overview of #radiotheranostics including what the immediate future might hold and a framework to approach it.
One natural next step is repurposing existing agents for other cancers.
1/x
